Patent · US Active

TRPV1 antagonists

US8802711B2 · kind B2 · utility

0Cited by

19References

25Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Arthur Gomtsyan · Vernon Hills, US
Jerome F. Daanen · Racine, US
Gregory A. Gfesser · Lindenhurst, US
Michael E. Kort · Lake Bluff, US
Chih-Hung Lee · Vernon Hills, US
Heath A. McDonald · Wonder Lake, US
Pamela S. Puttfarcken · Libertyville, US
Eric A. Voight · Pleasant Prairie, US
Philip R. Kym · Libertyville, US

Key dates

Filing date	Mar 22, 2012
Grant date	Aug 12, 2014
Priority date	—
Expiry date	Sep 15, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Disclosed herein are compounds of formula (I) or pharmaceutically acceptable salts, solvates, or combinations thereof,wherein X1, X2, X3, X4, J, K, L, X5, X6, Rb, G2, and m are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.